AngelaJainMD

Oncology • Philadelphia, PA

Assistant Professor

Join to view full profile

Dr. Jain is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Jain's full profile

Already have an account?

Office
333 Cottman Ave
Philadelphia, PA 19111
Phone+1 215-728-6900

Fax+1 215-214-3779

Education & Training

Temple University Hospital-Fox Chase Cancer CenterFellowship, Hematology and Medical Oncology, 2010 - 2013
Temple University HospitalResidency, Internal Medicine, 2007 - 2010
Lewis Katz School of Medicine at Temple UniversityClass of 2007

Certifications & Licensure

PA State Medical License 2007 - 2024
American Board of Internal Medicine Medical Oncology

Clinical Trials

Cabozantinib S-Malate in Treating Patients With Recurrent or Metastatic Endometrial Cancer Start of enrollment: 2013 Apr 29
Active, not recruiting
Phase 2
Metformin Hydrochloride, Carboplatin, and Paclitaxel in Treating Patients With Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Withdrawn
Phase 1
Paclitaxel and Carboplatin With or Without Metformin Hydrochloride in Treating Patients With Stage III, IV, or Recurrent Endometrial Cancer Start of enrollment: 2014 Mar 17
Active, not recruiting
Phase 2, Phase 3
A Study of Pembrolizumab in Combination With Epacadostat in Women With Recurrent/Metastatic Endometrial Carcinoma Start of enrollment: 2018 Sep 01
Withdrawn
Phase 2
A Study of RGX-104 in Patients With Advanced Lung & Endometrial Cancer Start of enrollment: 2016 Nov 01
Recruiting
Phase 1
Roles: Contact
Join now to see all

Publications & Presentations

PubMed

Population pharmacokinetics and exposure-response relationships of dostarlimab in primary advanced or recurrent endometrial cancer in part 1 of RUBY.
Mita Kuchimanchi, Trine Lembrecht Jørgensen, Eva Hanze, Thierry André, Angela Jain
British Journal of Clinical Pharmacology. 2024-11-08
NCCN Guidelines® Insights: Ovarian Cancer/Fallopian Tube Cancer/Primary Peritoneal Cancer, Version 3.2024.
Joyce Liu, Andrew Berchuck, Floor J Backes, Joshua Cohen, Rachel Grisham
Journal of the National Comprehensive Cancer Network. 2024-10-01
Endometrial Cancer Treatment: Long-Term Engagement Strategies.
Krisha J Howell, Angela Jain
International Journal of Radiation Oncology, Biology, Physics. 2024-02-01

Press Mentions

Biggest Cervical Cancer Drug Advance in 20 YearsNovember 2nd, 2023